-

$undefined

N/A

(N/A)

OKYO Pharma NASDAQ:OKYO OKYO Pharma is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of inflammatory eye diseases and chronic pain. The company's main focus is the clinical development of OK-101 to treat dry eye disease (DED).

Location: London, United Kingdom | Website: https://okyopharma.com/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

50.26M

Cash

987.2K

Avg Qtr Burn

-734.8K

Short % of Float

0.64%

Insider Ownership

27.61%

Institutional Own.

9.00%

Qtr Updated

09/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Urcosimod (OK-101) Details Neuropathic Corneal Pain	Phase 2b Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.